Jennifer Specht, MD

Breast Medical Oncologist, Professor @UWMedicine, Professor @Fredhutch

[ECOG-ACRIN Cancer Research Group @eaonc]

#FindingsFriday: ICYMI, yesterday at #SABCS25, @drjenspecht presented results from the EA1183/FEATURE trial in bone-dominant metastatic #BreastCancer. Read more about this major advance in #cancer imaging: https://t.co/7wj58T6bDv #bcsm #mbc

[Jennifer Specht, MD @drjenspecht]

@DAVAOnc @KUMedCenter Great session on novel immunotherapy strategies!

[DAVA Oncology @DAVAOnc]

Starting Now: Cellular Therapies and Vaccine Strategies
Moderated by: Dr. Priyanka Sharma @KUMedCenter
#DAVABreast

[JNM @JournalofNucMed]

A summary of the SNMMI procedure standard/EANM practice guideline for estrogen receptor imaging of patients with #BreastCancer using ¹⁸F-FES PET. https://t.co/DvMuCjWPWm

#NuclearMedicine #MedicalImaging @SNM_MI @EANM_NucMed

[ECOG-ACRIN Cancer Research Group @eaonc]

ECOG-ACRIN honored 46 member networks and programs for outstanding achievement in accrual, scientific contribution, & administrative participation in 2023. See the academic cancer centers, networks, community-based programs & principal investigators here: https://t.co/IK43N3WYHY

[ECOG-ACRIN Cancer Research Group @eaonc]

In phase 2 #ClinicalTrial EA1211/DIRECT, researchers are using an #imaging test called a FDG-PET/CT scan to try to better predict response to therapy for patients with #HER2positive #BreastCancer. Learn more: https://t.co/JdsOLY4xf8

[ECOG-ACRIN Cancer Research Group @eaonc]

EA1211/DIRECT aims to help doctors make better (more personalized) decisions around treatment for #patients with #HER2positive #BreastCancer. Consider learning more about this phase 2 #clinicaltrial if you have HER2-positive breast cancer. For more info: https://t.co/JdsOLY3ZpA

[Paolo Tarantino @PTarantinoMD]

The DAISY trial of T-DXd in MBC with variable HER2 expression is out on @NatureMedicine. Many important findings, including a similar ORR with T-DXd in HER2-low (37.5%) & HER2-0 (29.7%) MBC. Congrats to @FerMosele @FAndreMD et al for this impressive work! https://t.co/dIqTdLn78M

[Jennifer Specht, MD @drjenspecht]

@PatrickHwuMD @ASCO @BuddyGuys @sitcancer So great to see my amazing mentor and talented friend! @sitcancer @ASCO @PatrickHwuMD
@thecheckpoints

[Jennifer Specht, MD @drjenspecht]

Honored to participate and share updates in early breaat cancer. @btfoundation

[Binaytara @binaytara]

Enjoying the first session of the #BTFAlaska Multidisciplinary Oncology Conference with Dr. @drjenspecht! @UWMedicine @fredhutch @jrosalesmd @VMFHealth

[Jennifer Specht, MD @drjenspecht]

@eaonc @SeattleCCA @UWMedicine Thanks to partipating patients, their families, to our research team and Dr. Heather Jacene.

[ECOG-ACRIN Cancer Research Group @eaonc]

Researchers are testing an alternative approach to standard imaging to measure treatment response in patients w/ metastatic #breastcancer that has spread to the bones. FEATURE (the EA1183 trial) is led by @drjenspecht of @SeattleCCA @UWMedicine. For more: https://t.co/gaBp9MlVQK

[ECOG-ACRIN Cancer Research Group @eaonc]

If you have #breastcancer that has spread to the bones, you may be eligible for the FEATURE clinical trial, where researchers are studying if imaging with FDG-PET/CT is better than a standard bone scan to assess treatment response. Learn more: https://t.co/gaBp9MmtGi #BCSM

[Jennifer Specht, MD @drjenspecht]

@eaonc @SeattleCCA @UWMedicine Thanks to all our patients, their families and care teams for participating in this trial.

[ECOG-ACRIN Cancer Research Group @eaonc]

Researchers are testing an alternative approach to standard imaging to measure treatment response in patients w/ metastatic #breastcancer that has spread to the bones. FEATURE (the EA1183 trial) is led by @drjenspecht of @SeattleCCA @UWMedicine. For more: https://t.co/gaBp9MlVQK

[Jennifer Specht, MD @drjenspecht]

@YAbdouMD @StoverLab @OhioStateMed @OSUCCC_James Congrats Dr. Stover!!

[Harold J. Burstein, MD, PhD, FASCO @DrHBurstein]

Important question.

[Jennifer Specht, MD @drjenspecht]

@PatrickHwuMD Merry Christmas and Blessings for 2022!

[Jennifer Specht, MD @drjenspecht]

Honored to participate in Molecular Imaging and Breast Cancer - SABCS Open Event - SNMMI: https://t.co/1B5CyUoBTz

[Jennifer Specht, MD @drjenspecht]

@jrgralow Congratulations Julie!